1-(3,3-Dimethylbicyclo[2.2.1]hept-2-yl)ethan-1-one
Common Name: |
1-(3,3-Dimethylbicyclo[2.2.1]hept-2-yl)ethan-1-one |
IUPAC Name: |
1-(3,3-dimethyl-2-bicyclo[2.2.1]heptanyl)ethanone |
Molecular Formula: |
C11H18O |
SMILES: |
CC(=O)C1C2CCC(C2)C1(C)C |
Inchi: |
1S/C11H18O/c1-7(12)10-8-4-5-9(6-8)11(10,2)3/h8-10H,4-6H2,1-3H3 |
Inchi Key: |
NGTMQRCBACIUES-UHFFFAOYSA-N |
Cas No: |
42370-07-0 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
166.26 |
Mass (g/mol) |
166.136 |
Molar Refractivity |
50.70 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
1 |
Rings |
2 |
TPSA |
17.07 |
Hetero Atoms |
1 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
224.00 to 225.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.088 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.91 |
LogP |
2.648 |
iLOGP |
2.32 |
XLOGP3 |
2.79 |
WLOGP |
2.65 |
MLOGP |
2.59 |
ESOL Log S |
-2.56 |
ESOL Solubility (mg/ml) |
0.455 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-2.80 |
Ali Solubility (mg/ml) |
0.26 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.22 |
Silicos-IT Solubility (mg/ml) |
1.01 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.33 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.847 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.156 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |